EUVIMEDEUVIMED entdecken
Crossref

Design, Synthesis, and Evaluation of Pyrazole-Isoxazole Hybrids as Dual-Action Agents Against Biofilm-Forming Drug-Resistant Bacteria

Meena Kumari

INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH IN ENGINEERING AND MANAGEMENT · 13.04.2026 · 10 (04) · 1-9

DOI: 10.55041/ijsrem60010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH IN ENGINEERING AND MANAGEMENT, online erschienen am 13.04.2026. Verfasst von Meena Kumari.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The increasing rates of multidrug-resistant (MDR) bacterial infections with the complication of biofilm formation can pose a significant threat to global public health. The present work has involved rational design, synthesis and overall antimicrobial assessment of new pyrazole-isoxazole hybrid scaffolds which target non-adherent as well as adherent bacterial groups. compounds, N'-[(1-(4-chlorophenyl)-1H-pyrazol-4-yl)methylidene]-3-phenylisoxazole-5-carbohydrazide (H1) and N'-[(1-(4-methoxyphenyl)-1H-pyrazol-4-yl)methylidene]-3-phenylisoxazole-5-carbohydrazide (H2), were synthesized via acid-catalyzed condensation of substituted pyrazole-4-carbaldehydes with 3-phenylisoxazole-5-carbohydrazide, achieving yields of 82-85%. The structural elucidation was done using the 1H-NMR, FT-IR, ESI-MS. In vitro antimicrobial evaluation against clinically relevant drug-resistant strains of methicillin-resistant Staphylococcus aureus (MRSA ATCC-43300) and multidrug-resistant Pseudomonas aeruginosa (MDR-PA ATCC-27853) showed promising activity: MIC values were 6.25 to 25.0-μg/ml. It is worth highlighting that H2 with 4-methoxyphenyl substituent was more potent (MIC=6.25 μg/ml against MRSA) compared to the standard ciprofloxacin (MIC=16 μg/ml). Assays of crystal violet biofilm inhibition showed concentration-dependent effectiveness of antibiofilm; H2 exhibited 76.4% biofilm reduction at a half of MIC with MRSA. Time-kill kinetics proved the bactericidal effect, and > 4Log10 reduction of CFU at 2X MIC. These results set pyrazole-isoxazole hybrids as privileged scaffolds on the formation of subsequent-generation antimicrobials that can interfere with growth of bacteria and resistance by biofilm. Keywords: hybrids of pyrazole-isoxazole, antimicrobial action, biofilm formation, multidrug resistance, Methicillin-resistant Staphylococcus aureus, Pseudomonas aeruginosa, hydrazone.

Zitieren

APA

Kumari, M. (2026). Design, Synthesis, and Evaluation of Pyrazole-Isoxazole Hybrids as Dual-Action Agents Against Biofilm-Forming Drug-Resistant Bacteria. INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH IN ENGINEERING AND MANAGEMENT, 10(04), 1-9. https://doi.org/10.55041/ijsrem60010

Vancouver

Kumari M. Design, Synthesis, and Evaluation of Pyrazole-Isoxazole Hybrids as Dual-Action Agents Against Biofilm-Forming Drug-Resistant Bacteria. INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH IN ENGINEERING AND MANAGEMENT. 2026;10(04):1-9. doi:10.55041/ijsrem60010

BibTeX
@article{Kumari2026,
  author = {Kumari, Meena},
  title = {Design, Synthesis, and Evaluation of Pyrazole-Isoxazole Hybrids as Dual-Action Agents Against Biofilm-Forming Drug-Resistant Bacteria},
  journal = {INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH IN ENGINEERING AND MANAGEMENT},
  year = {2026},
  volume = {10},
  number = {04},
  pages = {1--9},
  doi = {10.55041/ijsrem60010}
}
Kostenlos starten →